abstract |
FIELD: medicine. n SUBSTANCE: as active agents, the composition contains triazavirin in an amount of 1.5-2.0 wt % and sea buckthorn oil in an amount of 1.5 - 2.0 wt %, whereas a gel base represents silicone glycerohydrogel Si(C 3 H 7 O 3 ) 4 ·6C 3 H 8 O 3 ·24H 2 O. n EFFECT: invention has high therapeutic activity and an increased rate of pathological element epithelisation alongside with no adverse side effect. n 5 ex |